She noticed reaches that the 92 percent two-year cancer-specific survival of patients with stage I non-small – promised and comparable to the rate achieved with radiation therapy. They concluded: A randomized, controlled trial comparing radiofrequency ablation with standard non-surgical treatment options is now guaranteed that to demonstrate the clinical benefit of this approach. .. The safety profile of the procedure was acceptable, coupled with no deaths or life-threatening complications with radiofrequency ablation. The main complications were pneumothorax in 27 patients and pleural effusion require drainage in four patients. None of the patients suffered significant deterioration of lung function and there were no deaths related to the procedure in one of the 137 ablation treatments performed.
Researchers in Europe, the USA and Australia assessed the effect of percutaneous radiofrequency ablation in a series of 106 patients with 183 small lung tumors . The tumors contain non-small-cell lung cancer in 33 patients, in 53 humans and metastases of other cancers in 20 patients. All patients were followed by their doctors. Considered unsuitable for surgery, radiotherapy or chemotherapy. Continue reading